Full name
LEK - POL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.99.Z - Production of other products not classified elsewhere
47.19.Z - Retail trade
47.61.Z - Retail sale of books
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
58.11.Z - Publishing of books
58.19.Z - Other publishing activities, excluding software publishing
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,4 | 0,3 | 0,1 | -72,6 |
Gross profit (loss) | 0,3 | 0,4 | 0 | -97,5 |
EBITDA | 0,3 | 0,4 | 0,1 | -85,2 |
Short time liabilities | 4 | 4,7 | 5,3 | 13,3 |
Other operating costs | 0,1 | 0,1 | 0,4 | 457,1 |
Equity capital | 2,3 | 2,5 | 2 | -20,2 |
Operating profit (EBIT) | 0,3 | 0,4 | 0 | -95,7 |
Assets | 6,2 | 7,1 | 7,3 | 1,7 |
Net profit (loss) | 0,2 | 0,4 | -0 | -111,1 |
Cash | 2 | 1,9 | 1,5 | -18,7 |
Liabilities and provisions for liabilities | 4 | 4,7 | 5,3 | 13,3 |
Net income from sale | 29,2 | 34,4 | 38,8 | 12,7 |
Working assets | 6,1 | 6,9 | 7,2 | 4,2 |
Other income costs | 0 | 0,2 | 0,3 | 52,3 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 10,4 | 16,1 | -2,2 | -18,3 |
Equity capital to total assets | 36,1 | 34,4 | 27 | -7,4 |
Gross profit margin | 1 | 1,1 | 0 | -1,1 |
EBITDA Margin | 1 | 1,2 | 0,2 | -1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 50 | 50 | 50 | 0 |
Current financial liquidity indicator | 1.5173044204711914 | 1.4825879335403442 | 1.3641785383224487 | -0,1 |
Net dept to EBITDA | -7.072590351104736 | -4.712430477142334 | -25.81963539123535 | -21,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane